Skip to main content
. 2016 Dec 9;55(1):435–440. doi: 10.1080/13880209.2016.1246574

Figure 2.

Figure 2.

Effects of comp on cell viability of bone marrow-derived dendritic cells (BMDCs). BMDCs were treated with comp (1–50 μM) for 18 h and viability was measured using MTT assay. Results shown are the mean ± SD of an experiment done in triplicate and are representative of three separate experiments. Comp, 3-hydroxy-4,7-megastigmadien-9-one.